Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Rob’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
Plans whose provider directory lists this clinician
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths
5.31 (4.24 to 6.37) · 8,661 cases
Worse
Jul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits
14.1 (12.7 to 15.7) · 2,191 cases
Worse
Jan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits
5.2 (4.4 to 6.2) · 2,191 cases
No different
Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits
5.1 · 425 cases
—None
Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits
9.6 · 158 cases
—None
Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits
19.6 · 183 cases
—None
Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits
12.7 (10.4 to 15.4) · 4,578 cases
No different
Jan 2022 – Dec 2024
What patients said (6,810 patients answered, 25% of those asked)
Patient survey stars by topic at Stanford Health Care
Cleanliness
4
Nurse communication
4
Doctor communication
4
Communication about medicines
3
Discharge information
4
Overall hospital rating
4
Quietness
2
Recommend hospital
5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean
75%
Nurses "always" communicated well
82%
Doctors "always" communicated well
81%
Staff "always" explained
63%
Yes, staff "did" give patients this information
89%
Yes, staff "did" give patients information about help after discharge
89%
Doctors "always" explained things so they could understand
76%
Doctors "always" listened carefully
80%
Doctors "always" treated them with courtesy and respect
87%
Patients who gave a rating of "9" or "10" (high)
79%
Staff "always" explained new medications
76%
Nurses "always" explained things so they could understand
77%
Nurses "always" listened carefully
79%
Nurses "always" treated them with courtesy and respect
88%
"Always" quiet at night
53%
"YES", patients would definitely recommend the hospital
83%
Staff "always" explained possible side effects
50%
Yes, staff "did" give patients information about possible symptoms
90%
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
Procedure volume Medicare published
Removal of nail tissue
1-10
—None
Removal of skin lesions
1-10
—None
Skin biopsy
1-10
—None
Medicaid work
$2,152 in 2024
Medicaid paid $2,152 for 56 billed services this clinician did in 2024, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
Largest Medicaid services in 2024
Short return visit (20+ min)
56
$2,152
Medicaid work by year
2024
56
1
14
$2,152
2023
26
1
14
$0
2021
12
1
12
$0
2019
27
1
14
$0
2018
28
1
14
$0
See the largest Medicaid services in earlier years
2023
Largest Medicaid services in 2023
Short return visit (20+ min)
26
$0
2021
Largest Medicaid services in 2021
Short return visit (20+ min)
12
$0
2019
Largest Medicaid services in 2019
Short return visit (20+ min)
27
$0
2018
Largest Medicaid services in 2018
Short return visit (20+ min)
28
$0
Drugs they prescribed that Part D paid
$226,390
Pharmacies billed $226,390 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 5% of their Part D prescriptions (185 of 3,843) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%.
3,313 generic and 495 brand-name prescriptions · $226,390 in drug cost · 227 antibiotic prescriptions to 173 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Largest Part D drug costs
Ozempic
46
$34,065
$741
Spiriva Respimat
34
$21,134
$622
Breyna
76
$18,471
$243
Jardiance
16
$8,756
$547
Wixela Inhub
19
$4,071
$214
See all 90 drugs
Every Part D drug this clinician prescribed
Ozempic
46
$34,065
$741
Spiriva Respimat
34
$21,134
$622
Breyna
76
$18,471
$243
Jardiance
16
$8,756
$547
Wixela Inhub
19
$4,071
$214
Typhim Vi
47
$3,995
$85
Havrix
52
$3,796
$73
Pradaxa
13
$3,686
$284
Alvesco
29
$3,269
$113
Boostrix Tdap
58
$3,074
$53
Twinrix
21
$2,541
$121
Atorvastatin
208
$2,521
$12
Humulin N
15
$2,504
$167
Levothyroxine
126
$2,336
$19
Fluticasone Propionate
87
$1,887
$22
Amlodipine Besylate
133
$1,692
$13
Losartan
119
$1,619
$14
Lisinopril
117
$1,503
$13
Lactulose
25
$1,482
$59
Gabapentin
54
$1,279
$24
Famotidine
82
$1,227
$15
Atovaquone-Proguanil
33
$1,139
$35
Hydrocodone-Acetaminophen
68
$1,111
$16
Albuterol Sulfate Hfa
57
$1,045
$18
Tamsulosin
55
$954
$17
Simvastatin
81
$945
$12
Atenolol
70
$910
$13
Trospium Chloride
19
$835
$44
Azithromycin
119
$753
$6
Trazodone
57
$701
$12
Triamcinolone Acetonide
28
$674
$24
Calcitonin-Salmon
12
$663
$55
Chlorhexidine Gluconate
17
$656
$39
Allopurinol
50
$592
$12
Adacel Tdap
11
$561
$51
Hydromorphone
26
$559
$22
Duloxetine
26
$549
$21
Metoprolol
42
$534
$13
Lorazepam
38
$534
$14
Pantoprazole
39
$526
$13
Hydrochlorothiazide
47
$498
$11
Hydralazine
18
$468
$26
Sertraline
37
$462
$12
Nystatin
18
$428
$24
Metformin Hcl Er
50
$427
$9
Acetaminophen-Codeine
34
$424
$12
Furosemide
35
$420
$12
Finasteride
28
$416
$15
Losartan-Hydrochlorothiazide
33
$412
$12
Montelukast
36
$409
$11
Metoprolol
35
$406
$12
Azelastine
23
$388
$17
Lisinopril-Hydrochlorothiazide
30
$370
$12
Lovastatin
28
$353
$13
Oxycodone
22
$345
$16
Doxycycline Monohydrate
13
$342
$26
Pravastatin
26
$340
$13
Ibuprofen
23
$318
$14
Amoxicillin-Clavulanate Potass
24
$318
$13
Metformin
21
$291
$14
Clopidogrel
15
$290
$19
Hydrocortisone
12
$274
$23
Tizanidine
18
$258
$14
Potassium Chloride
16
$256
$16
Fluoxetine
15
$235
$16
Fenofibrate
12
$209
$17
Celecoxib
14
$209
$15
Acyclovir
14
$208
$15
Mupirocin
21
$205
$10
Carvedilol
17
$198
$12
Neomycin-Polymyxin-Dexameth
12
$196
$16
Cefadroxil
17
$190
$11
Zolpidem
24
$181
$8
Oxycodone-Acetaminophen
11
$177
$16
Omeprazole
16
$175
$11
Alendronate
15
$158
$11
Buspirone
13
$156
$12
Spironolactone
14
$153
$11
Glipizide
13
$143
$11
Prednisone
17
$131
$8
Acetazolamide
15
$127
$8
Ondansetron Odt
13
$127
$10
Tramadol
16
$115
$7
Baclofen
14
$111
$8
Clonazepam
12
$102
$9
Meloxicam
15
$102
$7
Ondansetron
12
$96
$8
Ciprofloxacin
12
$92
$8
Alprazolam
11
$86
$8
Cyclobenzaprine
11
$70
$6
Year by year
Part D prescribing by year
2024
3,843
539
5% (185)
13%
$226,390
2023
3,790
557
5% (196)
13%
$230,283
2022
3,433
462
6% (210)
12%
$153,116
2021
3,420
362
6% (208)
12%
$158,835
2020
2,708
331
6% (153)
14%
$148,024
2019
3,234
390
6% (183)
16%
$192,006
2018
2,938
394
5% (159)
19%
$140,335
2017
2,737
349
8% (221)
—None
$130,485
2016
1,827
326
8% (143)
—None
$128,510
2015
922
162
3% (26)
—None
$66,323
2014
789
101
2% (15)
—None
$61,740
2013
254
67
5% (13)
—None
$16,273
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.